Introduction to the College on Problems of Drug Dependence Special Issue

Contemporary Advances in Opioid Neuropharmacology

Sharon L. Walsh, Ellen M. Unterwald, Sari E Izenwasser

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Opioid receptors are critical therapeutic targets for medications development relevant to the treatment of drug dependence and pain. With recent advances in molecular neurobiology, it has become evident that the functional activity of opioid receptors, as ligand-regulated protein complexes, is modulated by multifarious intracellular and extracellular events, that there is genetic variation in coding for receptors, and that the activity of endogenous opioid systems may underlie actions common to other addictive disorders. This supplemental issue of Drug and Alcohol Dependence, arising from an invited symposium at the 71st Annual Meeting of the College on Problems of Drug Dependence, provides a series of contemporary reviews focused on recent advances in opioid neuropharmacology. Each speaker provides herein an invited comprehensive review of the state of knowledge on a specific topic in opioid neuropharmacology. Evans and colleagues describe the multi-faceted control of the opioid G-protein coupled receptor as a dynamic " sensor" complex and identify novel targets for drug development. von Zastrow focuses on opioid receptor-mediated events regulated by endocytosis and membrane trafficking through the endocytic pathway and differential responses to opioid agonists. Blendy and colleague provide a review of human association studies on the functional relevance of the mu opioid receptor variant, A118G, and presents data from the A112G knock-in model, an analogous mouse variant to A118G. Finally, Maldonado and colleagues provide a broader systems review from genetic, pharmacologic and behavioral studies implicating the endogenous opioid systems as a substrate for the mediation of substance use disorders spanning pharmacological classes.

Original languageEnglish
Pages (from-to)153-155
Number of pages3
JournalDrug and Alcohol Dependence
Volume108
Issue number3
DOIs
StatePublished - May 1 2010

Fingerprint

Neuropharmacology
Opioid Analgesics
Opioid Receptors
Substance-Related Disorders
Pharmaceutical Preparations
Behavioral Genetics
Neurobiology
mu Opioid Receptor
G-Protein-Coupled Receptors
Endocytosis
Alcoholism
Alcohols
Pharmacology
Ligands
Membranes
Pain
Sensors
Substrates
Therapeutics

Keywords

  • Abuse
  • Analgesia
  • Genetics
  • Molecular biology
  • Opioid
  • Pharmacology
  • Receptor

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Introduction to the College on Problems of Drug Dependence Special Issue : Contemporary Advances in Opioid Neuropharmacology. / Walsh, Sharon L.; Unterwald, Ellen M.; Izenwasser, Sari E.

In: Drug and Alcohol Dependence, Vol. 108, No. 3, 01.05.2010, p. 153-155.

Research output: Contribution to journalArticle

@article{cbd97e0ab96b42dbb65da0576b527f96,
title = "Introduction to the College on Problems of Drug Dependence Special Issue: Contemporary Advances in Opioid Neuropharmacology",
abstract = "Opioid receptors are critical therapeutic targets for medications development relevant to the treatment of drug dependence and pain. With recent advances in molecular neurobiology, it has become evident that the functional activity of opioid receptors, as ligand-regulated protein complexes, is modulated by multifarious intracellular and extracellular events, that there is genetic variation in coding for receptors, and that the activity of endogenous opioid systems may underlie actions common to other addictive disorders. This supplemental issue of Drug and Alcohol Dependence, arising from an invited symposium at the 71st Annual Meeting of the College on Problems of Drug Dependence, provides a series of contemporary reviews focused on recent advances in opioid neuropharmacology. Each speaker provides herein an invited comprehensive review of the state of knowledge on a specific topic in opioid neuropharmacology. Evans and colleagues describe the multi-faceted control of the opioid G-protein coupled receptor as a dynamic {"} sensor{"} complex and identify novel targets for drug development. von Zastrow focuses on opioid receptor-mediated events regulated by endocytosis and membrane trafficking through the endocytic pathway and differential responses to opioid agonists. Blendy and colleague provide a review of human association studies on the functional relevance of the mu opioid receptor variant, A118G, and presents data from the A112G knock-in model, an analogous mouse variant to A118G. Finally, Maldonado and colleagues provide a broader systems review from genetic, pharmacologic and behavioral studies implicating the endogenous opioid systems as a substrate for the mediation of substance use disorders spanning pharmacological classes.",
keywords = "Abuse, Analgesia, Genetics, Molecular biology, Opioid, Pharmacology, Receptor",
author = "Walsh, {Sharon L.} and Unterwald, {Ellen M.} and Izenwasser, {Sari E}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.drugalcdep.2010.03.001",
language = "English",
volume = "108",
pages = "153--155",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Introduction to the College on Problems of Drug Dependence Special Issue

T2 - Contemporary Advances in Opioid Neuropharmacology

AU - Walsh, Sharon L.

AU - Unterwald, Ellen M.

AU - Izenwasser, Sari E

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Opioid receptors are critical therapeutic targets for medications development relevant to the treatment of drug dependence and pain. With recent advances in molecular neurobiology, it has become evident that the functional activity of opioid receptors, as ligand-regulated protein complexes, is modulated by multifarious intracellular and extracellular events, that there is genetic variation in coding for receptors, and that the activity of endogenous opioid systems may underlie actions common to other addictive disorders. This supplemental issue of Drug and Alcohol Dependence, arising from an invited symposium at the 71st Annual Meeting of the College on Problems of Drug Dependence, provides a series of contemporary reviews focused on recent advances in opioid neuropharmacology. Each speaker provides herein an invited comprehensive review of the state of knowledge on a specific topic in opioid neuropharmacology. Evans and colleagues describe the multi-faceted control of the opioid G-protein coupled receptor as a dynamic " sensor" complex and identify novel targets for drug development. von Zastrow focuses on opioid receptor-mediated events regulated by endocytosis and membrane trafficking through the endocytic pathway and differential responses to opioid agonists. Blendy and colleague provide a review of human association studies on the functional relevance of the mu opioid receptor variant, A118G, and presents data from the A112G knock-in model, an analogous mouse variant to A118G. Finally, Maldonado and colleagues provide a broader systems review from genetic, pharmacologic and behavioral studies implicating the endogenous opioid systems as a substrate for the mediation of substance use disorders spanning pharmacological classes.

AB - Opioid receptors are critical therapeutic targets for medications development relevant to the treatment of drug dependence and pain. With recent advances in molecular neurobiology, it has become evident that the functional activity of opioid receptors, as ligand-regulated protein complexes, is modulated by multifarious intracellular and extracellular events, that there is genetic variation in coding for receptors, and that the activity of endogenous opioid systems may underlie actions common to other addictive disorders. This supplemental issue of Drug and Alcohol Dependence, arising from an invited symposium at the 71st Annual Meeting of the College on Problems of Drug Dependence, provides a series of contemporary reviews focused on recent advances in opioid neuropharmacology. Each speaker provides herein an invited comprehensive review of the state of knowledge on a specific topic in opioid neuropharmacology. Evans and colleagues describe the multi-faceted control of the opioid G-protein coupled receptor as a dynamic " sensor" complex and identify novel targets for drug development. von Zastrow focuses on opioid receptor-mediated events regulated by endocytosis and membrane trafficking through the endocytic pathway and differential responses to opioid agonists. Blendy and colleague provide a review of human association studies on the functional relevance of the mu opioid receptor variant, A118G, and presents data from the A112G knock-in model, an analogous mouse variant to A118G. Finally, Maldonado and colleagues provide a broader systems review from genetic, pharmacologic and behavioral studies implicating the endogenous opioid systems as a substrate for the mediation of substance use disorders spanning pharmacological classes.

KW - Abuse

KW - Analgesia

KW - Genetics

KW - Molecular biology

KW - Opioid

KW - Pharmacology

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=77952422756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952422756&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2010.03.001

DO - 10.1016/j.drugalcdep.2010.03.001

M3 - Article

VL - 108

SP - 153

EP - 155

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 3

ER -